Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial

Double Blind ◽

Faculty Opinions recommendation of Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157457.617619 ◽

2009 ◽

Author(s):

Geoff Littlejohn

Keyword(s):

Clinical Trial ◽

Fibromyalgia Syndrome ◽

Sodium Oxybate ◽

Double Blind ◽

A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children

Medicine ◽

10.1097/md.0000000000023217 ◽

2020 ◽

Vol 99 (50) ◽

pp. e23217

Author(s):

Lina Wei ◽

Yina Guo ◽

Yutong Fei ◽

Lin Luo ◽

Caiwen Wang ◽

...

Keyword(s):

Clinical Trial ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Bacterial Pneumonia ◽

Efficacy And Safety ◽

Double Blind ◽

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial

Critical Care Medicine ◽

10.1097/00003246-199411000-00005 ◽

1994 ◽

Vol 22 (11) ◽

pp. 1720-1728 ◽

Cited By ~ 1

Author(s):

Jean-François A. Dhainaut ◽

Alain Tenaillon ◽

Yves Le Tulzo ◽

Benoit Schlemmer ◽

Jean-Pierre Solet ◽

...

Keyword(s):

Clinical Trial ◽

Severe Sepsis ◽

Receptor Antagonist ◽

Platelet Activating Factor ◽

Platelet Activating Factor Receptor

Double Blind ◽

Double Blind Placebo ◽

China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial

American Heart Journal ◽

10.1016/j.ahj.2020.06.011 ◽

2020 ◽

Vol 227 ◽

pp. 47-55

Author(s):

Yi Xu ◽

Xiangdong Li ◽

Haitao Zhang ◽

Yuan Wu ◽

Jun Zhang ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Clinical Trial ◽

Myocardial Protection ◽

Double Blind ◽

The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: A randomized, double-blind, placebo-controlled multicenter clinical trial

Journal of Ethnopharmacology ◽

10.1016/j.jep.2015.01.048 ◽

2015 ◽

Vol 164 ◽

pp. 71-77 ◽

Cited By ~ 31

Author(s):

Fengmei Lian ◽

Lie Wu ◽

Jiaxing Tian ◽

Ming Jin ◽

Shuiping Zhou ◽

...

Keyword(s):

Clinical Trial ◽

Diabetic Retinopathy ◽

Herbal Medicine ◽

Chinese Herbal Medicine ◽

Double Blind ◽

Double Blind Placebo ◽

Chinese Herbal

Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial

Applied Animal Behaviour Science ◽

10.1016/s0168-1591(99)00127-6 ◽

2000 ◽

Vol 67 (4) ◽

pp. 255-275 ◽

Cited By ~ 106

Author(s):

J.N. King ◽

B.S. Simpson ◽

K.L. Overall ◽

D. Appleby ◽

P. Pageat ◽

...

Keyword(s):

Clinical Trial ◽

Separation Anxiety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial

Arthritis & Rheumatism ◽

10.1002/art.34390 ◽

2012 ◽

Vol 64 (7) ◽

pp. 2387-2397 ◽

Cited By ~ 21

Author(s):

Lesley M. Arnold ◽

Ian Hirsch ◽

Paul Sanders ◽

Amanda Ellis ◽

Bernadette Hughes

Keyword(s):

Clinical Trial ◽

Double Blind ◽

Safety And Efficacy ◽

The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial

Immunology Letters ◽

10.1016/j.imlet.2014.10.026 ◽

2014 ◽

Vol 162 (2) ◽

pp. 185-193 ◽

Cited By ~ 2

Author(s):

Fulvio Braido ◽

Giovanni Melioli ◽

Piero Candoli ◽

Andrea Cavalot ◽

Mario Di Gioacchino ◽

...

Keyword(s):

Clinical Trial ◽

Respiratory Tract ◽

Recurrent Infections ◽

Bacterial Lysate ◽

Double Blind ◽

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial

Critical Care Medicine ◽

10.1097/00003246-199422110-00005 ◽

1994 ◽

Vol 22 (11) ◽

pp. 1720-1728 ◽

Cited By ~ 187

Author(s):

Jean-Francois A. Dhainaut ◽

Alain Tenaillon ◽

Yves Le Tulzo ◽

Benoit Schlemmer ◽

Jean-Pierre Solet ◽

...

Keyword(s):

Clinical Trial ◽

Severe Sepsis ◽

Receptor Antagonist ◽

Platelet Activating Factor ◽

Platelet Activating Factor Receptor

Double Blind ◽

Double Blind Placebo ◽

A Phase II Prospective, Randomized, Double‐Blind , Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting

The Oncologist ◽

10.1634/theoncologist.2020-0417 ◽

2020 ◽

Vol 25 (12) ◽

Author(s):

Pedro Sánchez‐Rovira ◽

Angelica Lindén Hirschberg ◽

Miguel Gil‐Gil ◽

Begoña Bermejo‐De Las Heras ◽

Concepción Nieto‐Magro

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Aromatase Inhibitor ◽

Hormone Receptor ◽

Early Stage ◽

Adjuvant Setting ◽

Double Blind ◽

Double Blind Placebo ◽

Hormone Receptor Positive